References
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708
- Wang F, Shu X, Meszoely I, et al. Overall mortality after diagnosis of breast cancer in men vs women. JAMA Oncol. 2019;5(11):1589. doi:10.1001/jamaoncol.2019.2803
- Konduri S, Singh M, Bobustuc G, Rovin R, Kassam A. Epidemiology of male breast cancer. Breast. 2020;54:8–14. doi:10.1016/j.breast.2020.08.010
- Miao H, Verkooijen HM, Chia KS, et al. Incidence and outcome of male breast cancer: an international population-based study. JCO. 2011;29(33):4381–4386. doi:10.1200/JCO.2011.36.8902
- Lautrup MD, Thorup SS, Jensen V, et al. Male breast cancer: a nation-wide population-based comparison with female breast cancer. Acta Oncologica. 2018;57(5):613–621. doi:10.1080/0284186X.2017.1418088
- Zeeshan S, Siddiqiui T, Shaukat F, Tariq MU, Khan N, Vohra L. Male breast cancer: the three decades’ experience of a tertiary care hospital in a lower-middle income country. Cureus. 2022. doi:10.7759/cureus.22670
- Anderson WF, Jatoi I, Tse J, Rosenberg PS. male breast cancer: a population-based comparison with female breast cancer. JCO. 2010;28(2):232–239. doi:10.1200/JCO.2009.23.8162
- Giordano SH. Breast Cancer in Men. J Med. 2018;378(24):2311–2320. doi:10.1056/NEJMra1707939
- Ly D, Forman D, Ferlay J, Brinton LA, Cook MB. An international comparison of male and female breast cancer incidence rates. Int J Cancer. 2013;132(8):1918–1926. doi:10.1002/ijc.27841
- Stang A, Thomssen C. Decline in breast cancer incidence in the United States: what about male breast cancer? Breast Cancer Res Treat. 2008;112(3):595–596. doi:10.1007/s10549-007-9882-3
- Leon-Ferre RA, Giridhar KV, Hieken TJ, et al. A contemporary review of male breast cancer: current evidence and unanswered questions. Cancer Metastasis Rev. 2018;37(4):599–614. doi:10.1007/s10555-018-9761-x
- Centers for Disease Control and Prevention. ICD-10: international statistical classification of diseases and related health problems; 2011.
- Microsoft Excel 16.63 Mac OS; 2022. Available from: https://support.microsoft.com/en-us/office/what-s-new-in-microsoft-365-95c8d81d-08ba-42c1-914f-bca4603e1426?ui=en-us&rs=en-us&ad=us. Accessed January 25, 2024.
- Stata BE 17 Mac OS; 2021. Available from: https://www.stata.com/products/mac/. Accessed January 25, 2024.
- Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547–569. doi:10.1177/0962280206070621
- Consonni D, Coviello E, Buzzoni C, Mensi C. A command to calculate age-standardized rates with efficient interval estimation. Stata J. 2012;12(4):688–701. doi:10.1177/1536867X1201200408
- ltable — life tables for survival data. Available from: https://www.stata.com/manuals/stltable.pdf. Accessed January 25, 2024.
- National Cancer Institute. Joinpoint regression program - surveillance research program. Available from: https://surveillance.cancer.gov/joinpoint/. Accessed January 25, 2024.
- Ilic L, Haidinger G, Simon J, Hackl M, Schernhammer E, Papantoniou K. Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017). Sci Rep. 2022;12(1):7048. doi:10.1038/s41598-022-10560-x
- Speirs V, Shaaban AM. The rising incidence of male breast cancer. Breast Cancer Res Treat. 2009;115(2):429–430. doi:10.1007/s10549-008-0053-y
- de Blok CJM, Wiepjes CM, Nota NM, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ. 2019:l1652. doi:10.1136/bmj.l1652
- Statistics Austria. Cancer in Austria [Krebserkrankungen in Österreich]; 2020: 78–83. Available from: https://www.statistik.at/services/tools/services/publikationen/detail/1122. Accessed September 28, 2022.
- Pizzato M, Carioli G, Bertuccio P, et al. Trends in male breast cancer mortality: a global overview. Eur J Cancer Prev. 2021;30(6):472–479. doi:10.1097/CEJ.0000000000000651
- Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260(2):103–117. doi:10.1111/j.1365-2796.2006.01677.x
- Gesamtbericht: Krebs in Niedersachsen 2020 mit Datenreport 2017–2018; 2020. Available from: https://www.krebsregister-niedersachsen.de/index.php/de-de/veroeffentlichungen/jahresberichte. Accessed March 24, 2022.
- Eisemann N, Waldmann A, Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration. BMC Med Res Methodol. 2011;11(1):129. doi:10.1186/1471-2288-11-129
- Brierley J, Gospodarowicz MK, Wittekind C, eds. TNM Classification of Malignant Tumours. 8th ed. John Wiley & Sons, Inc; 2017.
- Narod SA, Iqbal J, Miller AB. Why have breast cancer mortality rates declined? J Cancer Policy. 2015;5:8–17. doi:10.1016/j.jcpo.2015.03.002
- Hassett MJ, Somerfield MR, Baker ER, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol. 2020;38(16):1849–1863. doi:10.1200/JCO.19.03120
- Humphries MP, Sundara Rajan S, Honarpisheh H, et al. Characterisation of male breast cancer: a descriptive biomarker study from a large patient series. Sci Rep. 2017;7(1):45293. doi:10.1038/srep45293